Our data suggest that HDAC inhibition alone or in combination with standard chemotherapy may potentiate anaplastic thyroid cancer cells for immunotherapy. The gene discussed is HDAC9; the disease is thyroid gland undifferentiated (anaplastic) carcinoma.